<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03311971</url>
  </required_header>
  <id_info>
    <org_study_id>0428-17-RMC</org_study_id>
    <nct_id>NCT03311971</nct_id>
  </id_info>
  <brief_title>Single Center Study Evaluating the Possible Effect of Virtual Reality Spectacles on Pain Following Total Knee Replacement Surgery</brief_title>
  <official_title>Single Center Study Evaluating the Possible Effect of Virtual Reality Spectacles on Pain Following Total Knee Replacement Surgery</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Rabin Medical Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Rabin Medical Center</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The trial aims to evaulate the possiblity that use of virtual reality spectacles will affect
      post operative pain in total knee arthroplasty patients. The trial is a single center open
      label design. Patients will be randomized into two arm study comparing the effect of the use
      of virtual reality spectacles on pain levels and analgesic consumption in the perioperative
      period. The controls shall receive standard post operative care. The endpoints are VAS levels
      and analgesic use.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Evaluation Procedure This is a single center, interventional, randomized, unblinded two arm
      study assessing pain and analgesic use in post knee arthroplasty patients. The randomization
      ratio is 2:1 intervention to control. Both groups will receive routine post operative care.
      The intervention group will be treated with virtual reality spectacles. The control group
      will receive routine post operative care. Pain levels will be assessed using VAS and
      analgesic use.
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">November 30, 2017</start_date>
  <completion_date type="Anticipated">January 1, 2019</completion_date>
  <primary_completion_date type="Anticipated">September 30, 2018</primary_completion_date>
  <phase>Phase 2/Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>Comparison of intervention with conventional therapy. The intervention group includes use of virtual reality spectacles. The control group includes routine postoperative care</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>VAS pain response</measure>
    <time_frame>One week</time_frame>
    <description>questionnaires</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Analgesic use</measure>
    <time_frame>one week</time_frame>
    <description>amount of analgesic medication consumed</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">50</enrollment>
  <condition>Pain Post Joint Arthroplasty</condition>
  <arm_group>
    <arm_group_label>Conventional therapy</arm_group_label>
    <arm_group_type>Sham Comparator</arm_group_type>
    <description>Patient undergoing conventional analgesic therapy after total knee replacement</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Virtual reality glasses</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>treated with virtual glasses</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Virtual reality glasses</intervention_name>
    <description>Patients will be treated with virtual glasses</description>
    <arm_group_label>Virtual reality glasses</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>No VR glasses</intervention_name>
    <description>Patients will not use VR glasses</description>
    <arm_group_label>Conventional therapy</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients undergoing total knee arthroplasty gender indifferent, aged over 18 years old

          -  Patient with ability to see in three dimensions

        Exclusion Criteria:

          -  Inability to comply with the study protocol

          -  Single eye vision

          -  Blindness
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Hasharon Hospital</name>
      <address>
        <city>Petaáº– Tiqwa</city>
        <country>Israel</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Israel</country>
  </location_countries>
  <verification_date>October 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>August 30, 2017</study_first_submitted>
  <study_first_submitted_qc>October 16, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">October 17, 2017</study_first_posted>
  <last_update_submitted>October 16, 2017</last_update_submitted>
  <last_update_submitted_qc>October 16, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">October 17, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Rabin Medical Center</investigator_affiliation>
    <investigator_full_name>DROR ROBINSON</investigator_full_name>
    <investigator_title>Head of orthopedic research unit</investigator_title>
  </responsible_party>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Methamphetamine</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

